Department of Neurological Surgery, Miller School of Medicine University of Miami, Miami, FL, USA.
Department of Neurological Surgery, University of Washington, Seattle, WA, USA.
Clin Neurol Neurosurg. 2020 Oct;197:106199. doi: 10.1016/j.clineuro.2020.106199. Epub 2020 Sep 2.
The prediction of outcome after mechanical thrombectomy (MT) of basilar artery occlusion (BAO) remains an area of investigation. The objective of this study was to evaluate the prognostic role of presenting National Institute Health of Stroke Scale (NIHSS) scores in predicting favorable 90-day functional outcome. A survey of 7 electronic databases from inception to May 2020 was conducted following PRISMA guidelines. Articles were screened against pre-specified criteria. Multivariate odds ratios (ORs) for favorable 90-day function outcome (modified Rankin Score 0-2) were extracted and pooled by meta-analysis of proportions with random effects modeling. A total of 10 individual studies satisfied criteria for selection and described a total of 941 BAO patients managed by MT. Analysis revealed 590 (63%) males with a mean age of 66.6 years. The median presenting NIHSS was 19, and 316 (34%) patients were reported to have a favorable functional status 90-days after treatment. Lower presenting NIHSS scores independently and significantly predicted favorable 90-day functional outcome in BAO patients with a pooled OR of 0.89 (95% CI, 0.87-0.92; I = 18%; P-heterogeneity = 0.28). Meta-regression did not detect any clinical parameter that influenced this trend direction or its significance, and bias assessments were unremarkable. We confirm in this study via a consensus within the literature that the presenting NIHSS score predicts 90-day functional outcome in BAO patients treated by MT. Further, its standardized use allows more meaningful comparisons between interventions and anatomical locations.
机械取栓治疗基底动脉闭塞(BAO)后的预后预测仍然是一个研究领域。本研究的目的是评估基线国立卫生研究院卒中量表(NIHSS)评分在预测 90 天功能预后良好方面的预后作用。按照 PRISMA 指南,对从创建到 2020 年 5 月的 7 个电子数据库进行了调查。根据预先规定的标准筛选文章。通过随机效应模型的比例荟萃分析提取并汇总了有利于 90 天功能结局(改良 Rankin 评分 0-2)的多变量优势比(OR)。共有 10 项单独的研究符合入选标准,共描述了 941 例接受 MT 治疗的 BAO 患者。分析显示,590 例(63%)为男性,平均年龄为 66.6 岁。基线 NIHSS 中位数为 19,316 例(34%)患者在治疗后 90 天报告功能状态良好。较低的基线 NIHSS 评分独立且显著预测 BAO 患者 90 天的功能预后,合并 OR 为 0.89(95%CI,0.87-0.92;I = 18%;P 异质性=0.28)。Meta 回归未发现任何临床参数影响该趋势方向或其意义,且偏倚评估无明显异常。通过文献共识,我们在本研究中确认,基线 NIHSS 评分可预测接受 MT 治疗的 BAO 患者 90 天的功能结局。此外,其标准化使用允许在干预和解剖部位之间进行更有意义的比较。